Lv1
25 积分 2020-12-06 加入
CA-125 ELIMination Rate Constant K (KELIM) Is a Marker of Chemosensitivity in Patients with Ovarian Cancer: Results from the Phase II CHIVA Trial
4个月前
已完结
Prognostic value of CA125 kinetics, half-life, and nadir in the treatment of epithelial ovarian cancer: a systematic review and meta-analysis
4个月前
已完结
HER2-low expression in patients with advanced or metastatic solid tumors
6个月前
已完结
Antibody-Drug Conjugates in Gynecologic Cancer
7个月前
已关闭
Antibody-Drug Conjugates in Gynecologic Cancers
7个月前
已完结
Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study
7个月前
已完结
Development and Validation of Multiparametric MRI–based Radiomics Models for Preoperative Risk Stratification of Endometrial Cancer
1年前
已完结
MRI-based Radiomics Models for Pretreatment Risk Stratification of Endometrial Cancer
1年前
已完结
Think outside the box
2年前
已完结
Innovative Deszensuschirurgie ohne Gewebeersatz
2年前
已完结
皖公网安备34019202002308
